Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1113.98% is 394% below its 5-year average of -225.62%, near the high end of its 5-year range (-6120.93%–0.00%).
29.93% below its 12-month average of -857.34%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -352.70%.
OPERATING MARGIN
-1113.98%
OPERATING MARGIN AVG TTM
-857.34%
OPERATING MARGIN AVG 3Y
-488.78%
OPERATING MARGIN AVG 5Y
-225.62%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-29.93%
CURRENT VS 3Y AVG
-127.91%
CURRENT VS 5Y AVG
-393.75%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
RenovoRx, Inc.
Market Cap
$62.62M
Operating Margin
-1113.98%
TTM Avg
-857.34%
3Y Avg
-488.78%
5Y Avg
-225.62%
Market Cap
$62.78M
Operating Margin
-7.19%
TTM Avg
-4.82%
3Y Avg
-64.73%
5Y Avg
-128.10%
Market Cap
$63.02M
Operating Margin
2.49%
TTM Avg
-12.82%
3Y Avg
-6.08%
5Y Avg
-11.76%
Market Cap
$63.78M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-3242.03%
5Y Avg
-2392.63%
Market Cap
$64.18M
Operating Margin
-69.62%
TTM Avg
-71.11%
3Y Avg
-78.39%
5Y Avg
-54.75%
Market Cap
$60.42M
Operating Margin
0.00%
TTM Avg
-50285.49%
3Y Avg
-35733.57%
5Y Avg
-23822.38%
Market Cap
$60.02M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$65.85M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-215.03%
5Y Avg
-173.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RenovoRx, Inc. (RNXT) | $62.62M | -1113.98% | -857.34% | -488.78% | -225.62% |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | -7.19% | -4.82% | -64.73% | -128.10% |
| InterCure Ltd. (INCR)vs › | $63.02M | 2.49% | -12.82% | -6.08% | -11.76% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 0.00% | 0.00% | -3242.03% | -2392.63% |
| Alps Group Inc (ALPS)vs › | $64.18M | -69.62% | -71.11% | -78.39% | -54.75% |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | 0.00% | -50285.49% | -35733.57% | -23822.38% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| XBiotech Inc. (XBIT)vs › | $65.85M | 0.00% | 0.00% | -215.03% | -173.00% |
| Cingulate Inc. (CING)vs › | $65.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | -336.81% | -194.53% | -97.26% | -64.84% |
Gross Margin
70.9%
Operating Margin
-1114.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -352.70% |
| 2026-03-31 | -616.16% |
| 2025-12-31 | -1480.25% |
| 2025-09-30 | -1203.01% |
| 2025-06-30 | -634.60% |
| 2025-03-31 | -1578.68% |
| 2024-12-31 | -6120.93% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
